Oksikodon: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
WanaraLima (bicara | kontrib) Tidak ada ringkasan suntingan Tag: Suntingan visualeditor-wikitext |
k Menghapus Kategori:Opioida semisintetik; Menambah Kategori:Opioid semisintetik menggunakan HotCat |
||
(5 revisi perantara oleh 3 pengguna tidak ditampilkan) | |||
Baris 1:
{{Infobox drug|image2=Oxycodone structure.png|routes_of_administration=[[Oral administration|By mouth]], [[sublingual administration|sublingual]], [[intramuscular injection|intramuscular]], [[intravenous injection|intravenous]], [[intranasal administration|intranasal]], [[subcutaneous injection|subcutaneous]], [[transdermal administration|transdermal]], [[rectal administration|rectal]], [[epidural administration|epidural]]<ref name="Kalso">{{cite journal |author = Kalso E |title = Oxycodone |journal = Journal of Pain and Symptom Management |volume = 29 |issue = 5S |pages = S47–S56 |year = 2005 |pmid = 15907646 |doi = 10.1016/j.jpainsymman.2005.01.010|doi-access = free }}</ref>|duration_of_action=By mouth (IR): 3–6 hrs<ref name="SmithPassik2008">{{cite book |author1=Howard Smith |author2=Steven Passik |title=Pain and Chemical Dependency |url=https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |date=25 April 2008 |publisher=Oxford University Press USA |isbn=978-0-19-530055-0 |pages=195– |access-date=5 August 2020 |archive-date=17 April 2021 |archive-url=https://web.archive.org/web/20210417043152/https://books.google.com/books?id=T88C-9VTDXMC&pg=PA195 |url-status=live }}</ref><br />By mouth (CR): 10–12 hrs<ref name="sunshine1996">{{cite journal |first1=Abraham |last1=Sunshine |first2=Nancy Z. |last2=Olson |first3=Ariel |last3=Colon |first4=Juana |last4=Rivera |first5=Robert F. |last5=Kaiko |first6=Ronald D. |last6=Fitzmartin |first7=Robert F. |last7=Reder |first8=Paul D. |last8=Goldenheim |title=Analgesic Efficacy of Controlled-Release Oxycodone in Postoperative Pain |journal=Journal of Clinical Pharmacology |date=July 1996 |volume=36 |issue=7 |pages=595–603 |doi=10.1002/j.1552-4604.1996.tb04223.x |pmid=8844441 |quote=Treatment with CR oxycodone was safe and effective in this study, and its characteristics will be beneficial in the treatment of pain.}}</ref>|dependency_liability=High<ref>{{cite book |last1=Bonewit-West |first1=Kathy |last2=Hunt |first2=Sue A. |last3=Applegate |first3=Edith |title=Today's Medical Assistant: Clinical and Administrative Procedures |date=2012 |page=571 |publisher=Elsevier Health Sciences |isbn=9781455701506 |url=https://books.google.com/books?id=YalYPI1KqTQC&pg=PA571 |language=en |access-date=2020-08-05 |archive-date=2020-07-28 |archive-url=https://web.archive.org/web/20200728034412/https://books.google.com/books?id=YalYPI1KqTQC&pg=PA571 |url-status=live }}</ref>|legal_status=<!-- For countries not listed above -->|bioavailability=By mouth: 60–87%<ref name
'''Oksikodon''' adalah [[obat]] golongan opioid yang digunakan untuk mengatasi keluhan [[nyeri]] derajat sedang hingga derajat berat. <ref name="AHFS2018">{{Cite web|title=Oxycodone Monograph for Professionals |url=https://www.drugs.com/monograph/oxycodone.html |website=Drugs.com |publisher=AHFS |archive-date=28 December 2018 |archive-url=https://web.archive.org/web/20181228174726/https://www.drugs.com/monograph/oxycodone.html |url-status=live |access-date=28 December 2018}}</ref> Sediaan obat oksikodon yang diminum, memiliki sediaan yang beragam ada sediaan yang menggunakan formulasi pelepasan segera dan pelepasan terkontrol . <ref name="AHFS2018"
== Referensi ==
[[Kategori:
[[Kategori:
[[Kategori:4,5-Epoksimorfinan]]
[[Kategori:Euforian]]
[[Kategori:Opioid semisintetik]]
[[Kategori:Obat Esensial Organisasi Kesehatan Dunia]]
[[Kategori:Agonis reseptor mu-opioid]]
|